- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02959086
Shanghai Epidemiology Study for Adolescents and Children With Cancer
February 9, 2024 updated by: Children's Cancer Group, China
The purpose of this study is to describe the morbidity, mortality, disability and survival rate in Shanghai adolescents and children with cancer diagnosed since January 2002.
Study Overview
Status
Recruiting
Conditions
Detailed Description
The investigators collected information of all the adolescents and children diagnosed cancer in Shanghai since January 2002, including their name, gender, the date of birth, the diagnosis date, disease diagnosis, residence address and the last follow-up time status (survival/death).
The type of cancer included all malignant tumors such as Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, central nervous system tumors, Neuroblastoma, Wilms tumor and so on.
Then the investigators would analyze the morbidity, mortality, disability and survival rate.
Study Type
Observational
Enrollment (Estimated)
2000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Yi-Jin Gao, MD
- Phone Number: 0086-21-38626161
- Email: gaoyijin@scmc.com.cn
Study Contact Backup
- Name: Xing-Wei Wang, MD
- Phone Number: 0086-21-38626161
- Email: wangxingwei@scmc.com.cn
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200127
- Active, not recruiting
- Shanghai Children's Medical Center
-
Shanghai, Shanghai, China, 200336
- Recruiting
- Shanghai Municipal Center of Disease Prevention & Control
-
Contact:
- Ying Zheng, MS,MD
- Phone Number: 0086-21-62758710
-
Contact:
- Liang Shi, MD,MPH
- Phone Number: 0086-21-62758710
- Email: shiliang@scdc.sh.cn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 second to 19 years (Child, Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Since January 2002 in Shanghai, 0-19 year-old children and adolescents diagnosed with cancer.
Description
Inclusion Criteria:
- 0-19 year-old children and adolescents.
- Diagnosed cancer in Shanghai since January 2002.
Exclusion Criteria:
- Patients who were lost of follow-up.
- Patient's death wasn't caused by cancer or complications but by other accidents such as car accident, fell from a great height and so on.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
1
Patients were diagnosed since January 2002.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Overall survival for the whole cohort
Time Frame: 5 years
|
5 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Mortality for the whole cohort
Time Frame: 5 years
|
5 years
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Disability rate for the whole cohort
Time Frame: 5 years
|
5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Yi-Jin Gao, MD, Shanghai Children's Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2002
Primary Completion (Actual)
April 1, 2017
Study Completion (Estimated)
January 1, 2030
Study Registration Dates
First Submitted
November 7, 2016
First Submitted That Met QC Criteria
November 7, 2016
First Posted (Estimated)
November 8, 2016
Study Record Updates
Last Update Posted (Actual)
February 12, 2024
Last Update Submitted That Met QC Criteria
February 9, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- CCGChina
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Childhood Cancer
-
Australian & New Zealand Children's Haematology...Medical Research Future Fund; Minderoo Foundation; Children's Cancer Institute...RecruitingChildhood Cancer | Relapsed Cancer | Refractory Cancer | Childhood Leukemia | Childhood Solid Tumor | Childhood Brain TumorAustralia
-
University of Colorado, DenverRecruitingCancer | Childhood CancerUnited States
-
Children's Hospital of PhiladelphiaCompletedCancer | Childhood CancerUnited States
-
Sydney Children's Hospitals NetworkGerman Cancer Research Center; Australian & New Zealand Children's Haematology... and other collaboratorsActive, not recruitingChildhood Cancer | Relapsed Cancer | Refractory Cancer | Childhood Leukemia | Childhood Solid Tumor | Childhood Brain TumorAustralia
-
Wake Forest University Health SciencesTerminated
-
Gustave Roussy, Cancer Campus, Grand ParisActive, not recruiting
-
Pernille BidstrupOdense University Hospital; Aarhus University Hospital; Aarhus University Hospital... and other collaboratorsCompleted
-
Emory UniversityNational Cancer Institute (NCI)Recruiting
-
St. Jude Children's Research HospitalRecruiting
-
Technical University of MunichHelmholtz Zentrum MünchenCompleted